Prathiba Rathore, daughter of Dr. Bhuvan Chandra Rathore, currently
serving as the Deputy Registrar, Trademarks & Geographical Indications has
recently been selected for the BIRAC SRISTI Appreciation Award for her
invention titled, ‘Futuristic
Safe Injection System-2020’.
SRISTI has signed an
agreement with BIRAC-DBT to facilitate the Innovations by students and
grassroots people. The salient features of this agreement are to expand the
funnel for early stage student led ideas and innovations, sometimes only at proof of concept level, for
recognition and further development in the field of medical devices,
diagnostics and biotech applications for meeting unmet social needs in
extremely frugal and potentially sustainable manner. BIRAC-SRISTI GYTI Awards
and BIRAC-SRISTI Appreciation Awards were instituted under this Agreement.
BIRAC will support 100 grassroots and students (children’s) innovations. A
grant of INR 1 lakhs (USD 1550 approx.) each will be given to reveal the
science and develop product/prototype.
About
the Invention:
Keeping in mind that
safety in relation to injections and the hazardous bio-medical waste is a major
global healthcare concern being directly responsible for spreading various
dreadful diseases i.e. Hepatitis B/C, HIV/AIDS as well as other serious
communicable diseases leading to pre-mature deaths of 1.3 million people every
year. The invention titled, ‘Futuristic Safe Injection
System-2020’ provides a cheapest,
greener, sustainable, ergonomic disruptive technology compatible
with WHO’s guidelines, which will completely eliminate the need of
syringe ensuring ‘single dose-single needle’; preventing Needle Stick Injury,
needle-reuse, counterfeit drugs; reducing hazardous medical waste by
70-75% and ultimately saving millions of
lives & billions of dollars without creating any technological divide. It
consists of two variants of reusable injector and 18 variants of safely
disposable drug-cartridge containing inbuilt piston and retractable needle
along with a fixed dose of medicament, wherein needle retracts automatically
within the empty cartridge after the injection process.
The European Patent
Office, while examining its International Patent Application WO2016142799 has opined in the
following terms –
“The technical effect of these features is that the injector is reusable
while the only parts to be discarded are the needle hub and the medicament
cartridge. As a result a cheaper and friendlier to the environment system is
achieved without an increased risk of needle injuries.”
This technology will help
in democratizing healthcare system by making it equally affordable and
accessible to all. It will ensure fullest achievement of WHO’s initiatives to
completely replace conventional syringes with safety syringes by 2020 (to which
WHO has already imparted global leadership to India), meeting Sustainable
Development Goals (SDGs) by multi-fold benefits to healthcare system, reducing
healthcare concerns originating from Climate-Change and most importantly, in
achieving the highest goal of securing a safe, healthy and dignified ‘Right to
Life’ for all.
The inventors, a family of five members,
consisting of Jai Hind Rathore (son), Bharati Rathore & Pratibha Rathore
(daughters), Dr. Neelam Rathore (mother) and Dr. B. C. Rathore (father), have
earnestly dedicated more than a decade putting their entire efforts, labor, skill, energy, money and
all resources without seeking any kind of support from anyone in developing this invention. Inventors have voluntarily and delightfully offered a free of cost license to
WHO, UNICEF and RED-CROSS, so that the ultimate benefits of invention may
directly reach to the end-users in urgent need.
No comments:
Post a Comment